Published in:
01-12-2020 | Letter
Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
Authors:
Patrick M. Honore, Aude Mugisha, Luc Kugener, Sebastien Redant, Rachid Attou, Andrea Gallerani, David De Bels
Published in:
Critical Care
|
Issue 1/2020
Login to get access
Excerpt
We read with great interest the recent paper by Martucci et al. who concluded that high-dose vitamin D3 supplementation was associated with a reduction in 28-day mortality in a mixed population of critically ill adults with vitamin D deficiency [
1]. Their analysis also attempted to identify who may benefit the most from future vitamin D intervention trials [
1]. We would like to make some comments. In their paper, Martucci et al. did not include data regarding patients with acute kidney injury (AKI) needing renal replacement therapy (RRT) within the critically ill population they studied [
1]. …